股本结构
单位：万股
| 公告日期 | 2025-12-16 | 2025-12-16 | 2025-08-13 | 2025-08-13 | 2025-05-12 | 2025-05-12 |
|---|---|---|---|---|---|---|
| 证券总股本 | 13500.48 | 13446.10 | 13432.56 | 13402.22 | 13388.39 | 13383.60 |
| 普通股本 | 13500.48 | 13446.10 | 13432.56 | 13402.22 | 13388.39 | 13383.60 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-12-11 | 2025-09-30 | 2025-08-11 | 2025-06-30 | 2025-05-07 | 2025-03-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-12-16 | 13500.48 | 未披露 | 定期报告 | 2025-12-11 |
| 2025-12-16 | 13446.10 | 未披露 |
更多>>
From October 1, 2024 to September 30, 2025
Shares issued related to business combination, net of issue costs of $71
Private placement
Exercise of stock options
Exercise of restricted share units
Exercise of performance share units
|
2025-09-30 |
| 2025-08-13 | 13432.56 | 未披露 | 定期报告 | 2025-08-11 |
| 2025-08-13 | 13402.22 | 未披露 | 定期报告 | 2025-06-30 |
| 2025-05-12 | 13388.39 | 未披露 | 定期报告 | 2025-05-07 |
| 2025-05-12 | 13383.60 | 未披露 | 定期报告 | 2025-03-31 |
| 2025-03-03 | 12621.70 | 未披露 | 定期报告 | 2025-02-12 |
| 2024-12-18 | 10858.55 | 未披露 |
更多>>
From October 1, 2023 to September 30, 2024
Unit financing, net of issuance costs
Private placement
Exercise of stock options
Exercise of restricted share units
Exercise of performance share units
|
2024-09-30 |
| 2024-08-13 | 10380.14 | 未披露 | 定期报告 | 2024-06-30 |
| 2024-05-14 | 10336.96 | 未披露 | 定期报告 | 2024-05-13 |
| 2024-03-28 | 9446.86 | 未披露 | 定期报告 | 2024-03-26 |
| 2024-02-13 | 9409.79 | 未披露 | 定期报告 | 2024-02-12 |
| 2024-02-13 | 8116.16 | 未披露 | 定期报告 | 2023-12-31 |
| 2023-12-19 | 8116.20 | 未披露 | 定期报告 | 2023-12-15 |
| 2023-12-19 | 8116.16 | 未披露 |
更多>>
From September 1, 2022 to September 30, 2023
Shares issued to former shareholders of EIC, net of issue costs of $19
Exercise of stock options
Exercise of restricted share units
Exercise of performance share units
Rounding of fractional shares after share consolidation
|
2023-09-30 |
| 2023-09-25 | 8052.02 | 未披露 | 定期报告 | 2023-09-22 |
| 2023-07-14 | 8049.87 | 未披露 | 定期报告 | 2023-07-13 |
| 2023-07-06 | 8049.87 | 未披露 |
更多>>
Organigram Holdings Inc. announced it has completed the proposed consolidation of the Company's issued and outstanding common shares at a consolidation ratio of four (4) pre-consolidation common shares for every one (1) post-consolidation common share.
|
2023-07-07 |
| 2023-10-06 | 32199.48 | 未披露 | 定期报告 | 2023-07-05 |
| 2023-04-12 | 31393.86 | 未披露 | 定期报告 | 2023-02-28 |
| 2022-12-19 | 31385.69 | 未披露 | 定期报告 | 2022-12-16 |
| 2023-01-12 | 31385.69 | 未披露 | 定期报告 | 2022-11-30 |
| 2022-11-29 | 31381.55 | 未披露 | 定期报告 | 2022-08-31 |
| 2022-07-14 | 31370.78 | 未披露 | 定期报告 | 2022-05-31 |
| 2022-04-12 | 31368.98 | 未披露 | 定期报告 | 2022-02-28 |
| 2022-01-11 | 31081.76 | 未披露 | 定期报告 | 2022-01-10 |
| 2022-01-11 | 29984.94 | 未披露 | 定期报告 | 2021-11-30 |
| 2021-11-23 | 29878.60 | 未披露 |
更多>>
From September 1, 2020 to August 31, 2021
Unit financing, net of issue costs of $3,502
Private placement, net of issue costs of $1,174
Shares issued related to business combination, net of issue costs of $65
Exercise of stock options
Exercise of restricted share units
Exercise of performance share units
Exercise of warrants
|
2021-08-31 |
| 2021-08-31 | 29878.27 | 未披露 | 定期报告 | 2021-08-27 |
| 2021-07-13 | 29877.27 | 未披露 | 定期报告 | 2021-07-11 |
| 2021-06-24 | 29875.47 | 未披露 | 定期报告 | 2021-06-22 |
| 2021-07-13 | 29864.48 | 未披露 |
更多>>
From September 1, 2020 to May 31, 2021
Unit financing, net of issue costs of $3,502
Private placement, net of issue costs of $1,174
Shares issued related to business combination, net of issue costs of $65
Exercise of stock options
Exercise of restricted share units
Exercise of warrants
|
2021-05-31 |
| 2021-04-13 | 29823.26 | 未披露 | 定期报告 | 2021-04-11 |
| 2021-04-13 | 23481.13 | 未披露 |
更多>>
From September 1, 2020 to February 28, 2021
Unit financing net of issue costs of $3,502
Exercise of stock options
Exercise of restricted share units
Exercise of warrants
|
2021-02-28 |
| 2021-02-01 | 23216.15 | 未披露 | 定期报告 | 2021-01-15 |
| 2021-01-12 | 23210.90 | 未披露 | 定期报告 | 2021-01-10 |
| 2020-11-30 | 23208.82 | 未披露 | 定期报告 | 2020-11-28 |
| 2020-11-30 | 23208.80 | 未披露 | 定期报告 | 2020-11-24 |
| 2020-11-10 | 19471.32 | 未披露 | 定期报告 | 2020-11-09 |
| 2020-11-30 | 19451.11 | 未披露 |
更多>>
From September 1, 2019 to August 31, 2020
At-the-market equity financing, net of issue costs of $3,754
Exercise of stock options
Exercise of restricted share units
|
2020-08-31 |
| 2020-07-21 | 19450.71 | 未披露 | 定期报告 | 2020-07-17 |
| 2020-07-21 | 18720.33 | 未披露 | 定期报告 | 2020-05-31 |
| 2020-04-14 | 17307.89 | 未披露 |
更多>>
from September 1, 2019 to February 29, 2020
At-the-market equity financing, net of issue costs of $2,081
Exercise of stock options
Exercise of restricted share units
|
2020-02-29 |
| 2020-02-03 | 16359.14 | 未披露 | 定期报告 | 2020-01-17 |
| 2020-01-15 | 16357.07 | 未披露 | 定期报告 | 2020-01-12 |
| 2020-01-15 | 15624.34 | 未披露 |
更多>>
from September 1, 2019 to November 30, 2019
Exercise of stock options
|
2019-11-30 |
| 2019-11-27 | 15619.63 | 未披露 |
更多>>
from September 1, 2018 to August 31, 2019
Share-based compensation
Exercise of stock options
Exercise of warrants
Exercise of restricted share units
Conversion of debentures
|
2019-08-31 |
| 2019-07-15 | 15617.05 | 未披露 | 定期报告 | 2019-07-12 |
| 2019-07-15 | 15387.25 | 未披露 |
更多>>
from September 1, 2018 to May 31, 2019
Exercise of stock options
Exercise of warrants
Exercise of restricted share units
Conversion of debentures
Share-based compensation
|
2019-05-31 |
| 2019-05-21 | 15262.48 | 未披露 | 定期报告 | 2019-05-21 |
| 2019-04-29 | 12520.79 | 未披露 | 定期报告 | 2018-12-31 |
From October 1, 2024 to September 30, 2025
Shares issued related to business combination, net of issue costs of $71
Private placement
Exercise of stock options
Exercise of restricted share units
Exercise of performance share units
From October 1, 2023 to September 30, 2024
Unit financing, net of issuance costs
Private placement
Exercise of stock options
Exercise of restricted share units
Exercise of performance share units
From September 1, 2022 to September 30, 2023
Shares issued to former shareholders of EIC, net of issue costs of $19
Exercise of stock options
Exercise of restricted share units
Exercise of performance share units
Rounding of fractional shares after share consolidation
Organigram Holdings Inc. announced it has completed the proposed consolidation of the Company's issued and outstanding common shares at a consolidation ratio of four (4) pre-consolidation common shares for every one (1) post-consolidation common share.
From September 1, 2020 to August 31, 2021
Unit financing, net of issue costs of $3,502
Private placement, net of issue costs of $1,174
Shares issued related to business combination, net of issue costs of $65
Exercise of stock options
Exercise of restricted share units
Exercise of performance share units
Exercise of warrants
From September 1, 2020 to May 31, 2021
Unit financing, net of issue costs of $3,502
Private placement, net of issue costs of $1,174
Shares issued related to business combination, net of issue costs of $65
Exercise of stock options
Exercise of restricted share units
Exercise of warrants
From September 1, 2020 to February 28, 2021
Unit financing net of issue costs of $3,502
Exercise of stock options
Exercise of restricted share units
Exercise of warrants
From September 1, 2019 to August 31, 2020
At-the-market equity financing, net of issue costs of $3,754
Exercise of stock options
Exercise of restricted share units
from September 1, 2019 to February 29, 2020
At-the-market equity financing, net of issue costs of $2,081
Exercise of stock options
Exercise of restricted share units
from September 1, 2019 to November 30, 2019
Exercise of stock options
from September 1, 2018 to August 31, 2019
Share-based compensation
Exercise of stock options
Exercise of warrants
Exercise of restricted share units
Conversion of debentures
from September 1, 2018 to May 31, 2019
Exercise of stock options
Exercise of warrants
Exercise of restricted share units
Conversion of debentures
Share-based compensation